Eden Research plc (LON:EDEN – Get Free Report) insider Alexander John Abrey purchased 167,947 shares of Eden Research stock in a transaction that occurred on Tuesday, March 4th. The stock was bought at an average cost of GBX 3 ($0.04) per share, with a total value of £5,038.41 ($6,402.86).
Alexander John Abrey also recently made the following trade(s):
- On Tuesday, January 28th, Alexander John Abrey bought 540,540 shares of Eden Research stock. The shares were purchased at an average price of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,476.93).
Eden Research Stock Performance
Shares of Eden Research stock traded down GBX 0.05 ($0.00) on Tuesday, hitting GBX 3.10 ($0.04). The stock had a trading volume of 1,475,285 shares, compared to its average volume of 884,548. The company’s 50 day moving average price is GBX 3.78 and its 200 day moving average price is GBX 3.90. The stock has a market cap of £16.53 million, a price-to-earnings ratio of -10.86 and a beta of 0.92. The company has a current ratio of 3.80, a quick ratio of 2.42 and a debt-to-equity ratio of 1.26. Eden Research plc has a 52-week low of GBX 2.90 ($0.04) and a 52-week high of GBX 5.49 ($0.07).
Eden Research Company Profile
Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.
Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.
Featured Articles
- Five stocks we like better than Eden Research
- How to Calculate Stock Profit
- Tesla Stock: Finding a Bottom May Take Time
- Differences Between Momentum Investing and Long Term Investing
- Duolingo: This Beaten-Down Stock Is About to Rally 38%
- Where to Find Earnings Call Transcripts
- Zoom Stock: Leading the Video Market After Skype’s Exit
Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.